Dow Jones

39,851.60

0.74%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

NEXM

Nexmed (MM) (NEXM)

Nexmed (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NEXM

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
10/09/2010	16:11	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NEXM	Nexmed (MM)
10/09/2010	15:31	Business Wire	NexMed, Inc. Announces Results of Special Meeting of Stockholders, Including Name Change to Apricus Biosciences	NASDAQ:NEXM	Nexmed (MM)
31/08/2010	16:18	Edgar (US Regulatory)	Securities Registration Statement (S-1)	NASDAQ:NEXM	Nexmed (MM)
25/08/2010	10:00	Business Wire	NexMed To Present at the Rodman & Renshaw 12th Annual Healthcare Conference	NASDAQ:NEXM	Nexmed (MM)
23/08/2010	08:00	Business Wire	NexMed Receives Additional Patent Coverage for Israel	NASDAQ:NEXM	Nexmed (MM)
17/08/2010	05:03	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:NEXM	Nexmed (MM)
12/08/2010	16:10	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:NEXM	Nexmed (MM)
11/08/2010	08:15	Business Wire	NexMed Announces 2010 Second Quarter Financial Results Conference Call	NASDAQ:NEXM	Nexmed (MM)
06/08/2010	13:34	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	NASDAQ:NEXM	Nexmed (MM)
26/07/2010	11:36	Business Wire	Mohamed Hachicha, Ph.D. Joins NexMed, Inc. as Vice President-Research and Development for NexMed, USA	NASDAQ:NEXM	Nexmed (MM)
21/06/2010	08:15	GlobeNewswire Inc.	Emerging Stock Report Initiates Independent Research Coverage on NexMed, Inc.	NASDAQ:NEXM	Nexmed (MM)
15/06/2010	13:48	Business Wire	NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...	NASDAQ:NEXM	Nexmed (MM)
10/06/2010	12:30	Business Wire	NexMed Provides Update on Canadian Filing for Vitaros®	NASDAQ:NEXM	Nexmed (MM)
26/05/2010	17:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NEXM	Nexmed (MM)
25/05/2010	16:00	Business Wire	NexMed Announces Expansion of Senior Business Development Team	NASDAQ:NEXM	Nexmed (MM)
17/05/2010	16:11	Business Wire	NexMed to Discuss P2/3 Protocol for NexACT®-Based Alprostadil Treatment for Raynaud’s Syndrome with the FDA	NASDAQ:NEXM	Nexmed (MM)
12/05/2010	15:30	Business Wire	NexMed Announces Pre-Clinical Study Showing Vitaros® Significantly Promotes Wound Healing	NASDAQ:NEXM	Nexmed (MM)
10/05/2010	16:19	Business Wire	NexMed Announces Encouraging Pre-Clinical Results Showing the Ability of the NexACT® Technology to Enhance the Bioavailabili...	NASDAQ:NEXM	Nexmed (MM)
07/05/2010	04:50	GlobeNewswire Inc.	BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfit	NASDAQ:NEXM	Nexmed (MM)
06/05/2010	15:45	Business Wire	NexMed Expands Scientific Advisory Board with Appointment of Key Industry Leaders	NASDAQ:NEXM	Nexmed (MM)
05/05/2010	15:36	Business Wire	NexMed Announces Patent Allowance for NexACT® in Canada	NASDAQ:NEXM	Nexmed (MM)
30/04/2010	13:53	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:NEXM	Nexmed (MM)
28/04/2010	17:47	Business Wire	Pre-Clinical Results Show NexACT® Technology Significantly Improves Subcutaneous Delivery & Anti-Metastatic Activity of Angs...	NASDAQ:NEXM	Nexmed (MM)
27/04/2010	15:40	Business Wire	NexMed Appoints Dr. Stephen B. Howell, World Renowned Key Opinion Leader in Oncology as Chairman of Its Scientific Advisory B...	NASDAQ:NEXM	Nexmed (MM)
27/04/2010	07:30	Marketwired	Market Pulse Breaking News Alert for Tuesday, April 27, 2010: MZEI -- Implications of Test Results Are Enormous to Medizone as t	NASDAQ:NEXM	Nexmed (MM)
26/04/2010	15:45	Business Wire	NexMed Receives FDA Clearance for PrevOnco™ Phase 2 Study as First-Line Therapy for HCC	NASDAQ:NEXM	Nexmed (MM)
22/04/2010	19:50	Business Wire	NexMed Files CMC Response with Health Canada for Vitaros®	NASDAQ:NEXM	Nexmed (MM)
21/04/2010	16:24	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(5) (424B5)	NASDAQ:NEXM	Nexmed (MM)
20/04/2010	05:02	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:NEXM	Nexmed (MM)
19/04/2010	05:00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:NEXM	Nexmed (MM)